Editor's choice

Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis
Su-Jin Moon, Jung Min Bae, Kyung-Su Park, Ilias Tagkopoulos, Ki-Jo Kim

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 817-825; DOI: 10.1136/annrheumdis-2018-214778
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
Wanlong Wu, Suzana Jordan, Nicole Graf, Janethe de Oliveira Pena, John Curram, Yannick Allanore, Marco Matucci-Cerinic, Janet E Pope, Christopher P Denton, Dinesh Khanna, Oliver Distler

Annals of the Rheumatic Diseases May 2019, 78 (5) 648-656; DOI: 10.1136/annrheumdis-2018-213455
Genetics of rheumatoid arthritis: 2018 status
Yukinori Okada, Stephen Eyre, Akari Suzuki, Yuta Kochi, Kazuhiko Yamamoto

Annals of the Rheumatic Diseases Apr 2019, 78 (4) 446-453; DOI: 10.1136/annrheumdis-2018-213678
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity
Diogo Jesus, Ana Matos, Carla Henriques, Margherita Zen, Maddalena Larosa, Luca Iaccarino, José António Pereira Da Silva, Andrea Doria, Luís Sousa Inês

Annals of the Rheumatic Diseases Mar 2019, 78 (3) 365-371; DOI: 10.1136/annrheumdis-2018-214502
Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data
Alexander Tracy, Anuradhaa Subramanian, Nicola J Adderley, Paul Cockwell, Charles Ferro, Simon Ball, Lorraine Harper, Krishnarajah Nirantharakumar

Annals of the Rheumatic Diseases Feb 2019, 78 (2) 261-269; DOI: 10.1136/annrheumdis-2018-214142
Gene editing for inflammatory disorders
David T Ewart, Erik J Peterson, Clifford J Steer

Annals of the Rheumatic Diseases Jan 2019, 78 (1) 6-15; DOI: 10.1136/annrheumdis-2018-213454
Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonoti Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1720-1729; DOI: 10.1136/annrheumdis-2018-213920
Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study
Eldad Ben-Chetrit, Marco Gattorno, Ahmet Gul, Daniel L Kastner, Helen J Lachmann, Isabelle Touitou, Nicolino Ruperto

Annals of the Rheumatic Diseases Nov 2018, 77 (11) 1558-1565; DOI: 10.1136/annrheumdis-2017-212515
Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry
Sytske Anne Bergstra, Jaime C Branco, David Vega-Morales, Karen Salomon-Escoto, Nimmisha Govind, Cornelia F Allaart, Robert B M Landewé

Annals of the Rheumatic Diseases Oct 2018, 77 (10) 1413-1420; DOI: 10.1136/annrheumdis-2018-213289
Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis
Gabriella Moroni, Paolo Gilles Vercelloni, Silvana Quaglini, Mariele Gatto, Davide Gianfreda, Lucia Sacchi, Francesca Raffiotta, Margherita Zen, Gloria Costantini, Maria Letizia Urban, Federico Pieruzzi, Piergiorgio Messa, Augusto Vaglio, Renato Alberto Sinico, Andrea Doria

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1318-1325; DOI: 10.1136/annrheumdis-2017-212732

Main menu

Editor's choice

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Editor's choice

Pages